SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Lilly GLP-1 meds covered by CVS

CVS to cover Lilly's GLP-1 medications, expanding access to millions. Lilly's Foundayo and Zepbound may see increased demand.

LLY

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories